Cargando…

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents

Ovarian cancer is a common tumor of the reproductive system, and primarily responds to cytoreductive surgery and cisplatin (DDP)-based chemotherapy. However, chemoresistance results in high ovarian cancer mortality. Therefore, the aim of the present study was to investigate the effects of metformin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chen, Zhao, Nanan, Li, Dandan, Zou, Ge, Chen, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676676/ https://www.ncbi.nlm.nih.gov/pubmed/31402943 http://dx.doi.org/10.3892/ol.2019.10564

Ejemplares similares

Effect of metformin on the proliferation, apoptosis, invasion and autophagy of ovarian cancer cells
por: Zou, Ge, et al.
Publicado: (2019)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
por: Kosowska, Agnieszka, et al.
Publicado: (2020)

Knockdown of Snail Sensitizes Pancreatic Cancer Cells to Chemotherapeutic Agents and Irradiation
por: Zhang, Kejun, et al.
Publicado: (2010)

Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents
por: Garrison, Jason B, et al.
Publicado: (2015)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes
por: James, Nicole E., et al.
Publicado: (2019)

Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
por: Frampton, Gabriel, et al.
Publicado: (2010)

Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells
por: Paxson, Allan I., et al.
Publicado: (2023)

Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy
por: Li, Fu, et al.
Publicado: (2019)

Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents
por: Grimberg, Dominic C., et al.
Publicado: (2020)

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
por: García-Rodríguez, Francisco Javier, et al.
Publicado: (2018)

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
por: Liu, Rong, et al.
Publicado: (2017)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023)

Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents
por: Kongpetch, Sarinya, et al.
Publicado: (2012)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells
por: Li, Shuqing, et al.
Publicado: (2016)

The Sensitivity to Chemotherapeutic Agents of a Rat Tumour Grown in Immunosuppressed Mice
por: Sheard, Christine E., et al.
Publicado: (1971)

Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines
por: Fabi, François, et al.
Publicado: (2021)

Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines
por: Vural, Suleyman, et al.
Publicado: (2021)

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents
por: Díaz-Montero, C Marcela, et al.
Publicado: (2005)

Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents
por: Bao, Jiaolin, et al.
Publicado: (2015)

Photothermal transforming agent and chemotherapeutic co-loaded electrospun nanofibers for tumor treatment
por: Zhao, Jiulong, et al.
Publicado: (2019)

Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
por: Bojko, Agnieszka, et al.
Publicado: (2019)

Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents
por: Liu, Weiming, et al.
Publicado: (2022)

Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line
por: Aydemir, Isil, et al.
Publicado: (2020)

Current Research and Development of Chemotherapeutic Agents for Melanoma
por: Hsan, Kyaw Minn, et al.
Publicado: (2010)

Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents
por: Nakagawa-Saito, Yurika, et al.
Publicado: (2023)

Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells
por: Li, Hai-zhi, et al.
Publicado: (2008)

Interface of post-translational glycosylation and endoplasmic reticulum stress in melanoma: target to cancer cell sensitization to chemotherapeutic agents?
por: Lourenço, Luiza HM, et al.
Publicado: (2013)

Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
por: Lee, Ming-Cheng, et al.
Publicado: (2020)

Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors
por: Kim, Daejin, et al.
Publicado: (2010)

Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
por: Srijiwangsa, Pimradasiri, et al.
Publicado: (2018)

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
por: Litchfield, Lacey M., et al.
Publicado: (2015)

Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin
por: Šimčíková, Daniela, et al.
Publicado: (2021)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
por: Tossetta, Giovanni
Publicado: (2022)

Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells
por: Wang, Fang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ocfuh1ikpk2n0nb1c7ojtt4fs0